The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Plasma Ceramides Are Elevated in Obese Subjects With Type 2 Diabetes and Correlate With the Severity of Insulin Resistance
Open accessAbstract
OBJECTIVE—To quantitate plasma ceramide subspecies concentrations in obese subjects with type 2 diabetes and relate these plasma levels to the severity of insulin resistance. Ceramides are a putative mediator of insulin resistance and lipotoxicity, and accumulation of ceramides within tissues in obese and diabetic subjects has been well described. RESEARCH DESIGN AND METHODS—We analyzed fasting plasma ceramide subspecies by quantitative tandem mass spectrometry in 13 obese type 2 diabetic patients and 14 lean healthy control subjects. Results were related to insulin sensitivity measured with the hyperinsulinemic-euglycemic clamp technique and with plasma tumor necrosis factor-α (TNF-α) levels, a marker of inflammation. Ceramide species (C18:1, 18:0, 20:0, 24:1, and 24:0) were quantified using electrospray ionization tandem mass spectrometry after separation with high-performance liquid chromatography. RESULTS—Insulin sensitivity (mg · kg−1 · min−1) was lower in type 2 diabetic patients (4.90 ± 0.3) versus control subjects (9.6 ± 0.4) (P < 0.0001). Type 2 diabetic subjects had higher (P < 0.05) concentrations of C18:0, C20:0, C24:1, and total ceramide. Insulin sensitivity was inversely correlated with C18:0, C20:0, C24:1, C24:0, and total ceramide (all P < 0.01). Plasma TNF-α concentration was increased (P < 0.05) in type 2 diabetic subjects and correlated with increased C18:1 and C18:0 ceramide subspecies. CONCLUSIONS—Plasma ceramide levels are elevated in type 2 diabetic subjects and may contribute to insulin resistance through activation of inflammatory mediators, such as TNF-α.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.013 · Cited by 1,990
Pathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.013 · Cited by 1,342
Self-citationTumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link
Hotamisligil, G. S., & Spiegelman, B. M. (1994) · Diabetes · doi:10.2337/diab.43.11.1271 · Cited by 1,281
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s055 · Cited by 1,062
Ceramides in insulin resistance and lipotoxicity
SUMMERS, S. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.002 · Cited by 848
TNF-α Is a Predictor of Insulin Resistance in Human Pregnancy
Kirwan, J. P., Hauguel-De Mouzon, S., Lepercq, J., Challier, J.-C., Huston-Presley, L., Friedman, J. E., Kalhan, S. C., & Catalano, P. M. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2207 · Cited by 738
Self-citationUnger, R. H. (2003) · Endocrinology · doi:10.1210/en.2003-0870 · Cited by 677
Ceramide Content Is Increased in Skeletal Muscle From Obese Insulin-Resistant Humans
Adams, J. M., Pratipanawatr, T., Berria, R., Wang, E., DeFronzo, R. A., Sullards, M. C., & Mandarino, L. J. (2004) · Diabetes · doi:10.2337/diabetes.53.1.25 · Cited by 668
Self-citationHolland, W. L., & Summers, S. A. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0025 · Cited by 595
Schmitz-Peiffer, C., Craig, D. L., & Biden, T. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24202 · Cited by 592
Stern, I., & Shapiro, B. (1953) · Journal of Clinical Pathology · doi:10.1136/jcp.6.2.158 · Cited by 568
Muscle and Liver Insulin Resistance Indexes Derived From the Oral Glucose Tolerance Test
Abdul-Ghani, M. A., Matsuda, M., Balas, B., & DeFronzo, R. A. (2007) · Diabetes Care · doi:10.2337/dc06-1519 · Cited by 555
Self-citationKashyap, S., Belfort, R., Gastaldelli, A., Pratipanawatr, T., Berria, R., Pratipanawatr, W., Bajaj, M., Mandarino, L., DeFronzo, R., & Cusi, K. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2461 · Cited by 503
Self-citationLipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover.
Unger, R. H., & Zhou, Y. T. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s118 · Cited by 482
Physiology and pathophysiology of sphingolipid metabolism and signaling
Huwiler, A., Kolter, T., Pfeilschifter, J., & Sandhoff, K. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00042-1 · Cited by 432
Peraldi, P., Hotamisligil, G. S., Buurman, W. A., White, M. F., & Spiegelman, B. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.13018 · Cited by 412
Plasma Sphingomyelin Level as a Risk Factor for Coronary Artery Disease
Jiang, X.-C., Paultre, F., Pearson, T. A., Reed, R. G., Francis, C. K., Lin, M., Berglund, L., & Tall, A. R. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.12.2614 · Cited by 386
Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients
Drobnik, W., Liebisch, G., Audebert, F.-X., Fröhlich, D., Glück, T., Vogel, P., Rothe, G., & Schmitz, G. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200401-jlr200 · Cited by 350
Tumor necrosis factor alpha: a key component of the obesity-diabetes link
Hotamisligil, G. S., & Spiegelman, B. M. (1994) · Diabetes · doi:10.2337/diabetes.43.11.1271 · Cited by 349
Zhou, H., Summers, S. A., Birnbaum, M. J., & Pittman, R. N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16568 · Cited by 347
Schissel, S. L., Jiang, X.-C., Tweedie-Hardman, J., Jeong, T.-S., Camejo, E. H., Najib, J., Rapp, J. H., Williams, K. J., & Tabas, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2738 · Cited by 322
Tumor Necrosis Factor-α Induces Apoptosis of Human Adipose Cells
Prins, J. B., Niesler, C. U., Winterford, C. M., Bright, N. A., Siddle, K., O'Rahilly, S., Walker, N. I., & Cameron, D. P. (1997) · Diabetes · doi:10.2337/diab.46.12.1939 · Cited by 308
Reliability and validity of bioelectrical impedance in determining body composition
Jackson, A. S., Pollock, M. L., Graves, J. E., & Mahar, M. T. (1988) · Journal of Applied Physiology · doi:10.1152/jappl.1988.64.2.529 · Cited by 306
Altered Adipose and Plasma Sphingolipid Metabolism in Obesity
Samad, F., Hester, K. D., Yang, G., Hannun, Y. A., & Bielawski, J. (2006) · Diabetes · doi:10.2337/db06-0330 · Cited by 279
Human Vascular Endothelial Cells Are a Rich and Regulatable Source of Secretory Sphingomyelinase
Marathe, S., Schissel, S. L., Yellin, M. J., Beatini, N., Mintzer, R., Williams, K. J., & Tabas, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4081 · Cited by 273
Sphingolipids in Atherosclerosis and Vascular Biology
Chatterjee, S. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.10.1523 · Cited by 242
Dysfunctional fat cells, lipotoxicity and type 2 diabetes
Defronzo, R. A. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-504x.2004.00389.x · Cited by 236
Self-citationTNF-α impairs insulin signaling and insulin stimulation of glucose uptake in C2C12muscle cells
del Aguila, L. F., Claffey, K. P., & Kirwan, J. P. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.5.e849 · Cited by 235
Self-citationHajduch, E., Balendran, A., Batty, I. H., Litherland, G. J., Blair, A. S., Downes, C. P., & Hundal, H. S. (2001) · Diabetologia · doi:10.1007/s001250051596 · Cited by 235
Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes
Straczkowski, M., Kowalska, I., Baranowski, M., Nikolajuk, A., Otziomek, E., Zabielski, P., Adamska, A., Blachnio, A., Gorski, J., & Gorska, M. (2007) · Diabetologia · doi:10.1007/s00125-007-0781-2 · Cited by 218
Uptake and Metabolism of Sphingolipids in Isolated Intestinal Loops of Mice
Schmelz, E.-M., Crall, K. J., Larocque, R., Dillehay, D. L., & Merrill, A. H. (1994) · The Journal of Nutrition · doi:10.1093/jn/124.5.702 · Cited by 199
Metabolism of sphingomyelin in the intestinal tract of the rat
Nilsson, Å. (1968) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(68)90187-2 · Cited by 174
Wong, M., Xie, B., Beatini, N., Phu, P., Marathe, S. V., Johns, A., Gold, P. W., Hirsch, E., Williams, K. J., Licinio, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150098097 · Cited by 157
Goodpaster, B. H., & Kelley, D. E. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0086-2 · Cited by 155
Kanety, H., Hemi, R., Papa, M. Z., & Karasik, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9895 · Cited by 153
Kashyap, S., Roman, L. J., Lamont, J., Masters, B. S. S., Bajaj, M., Suraamornkul, S., Belfort, R., Berria, R., Kellogg, D. L., Liu, Y., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0745 · Cited by 141
Self-citationHuman skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity
Skovbro, M., Baranowski, M., Skov-Jensen, C., Flint, A., Dela, F., Górski, J., & Helge, J. W. (2008) · Diabetologia · doi:10.1007/s00125-008-1014-z · Cited by 133
Nelson, J. C., Jiang, X., Tabas, I. A., Tall, A. R., & Shea, S. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj140 · Cited by 131
Lightle, S. A., Oakley, J. I., & Nikolova‐Karakashian, M. (2000) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(00)00191-3 · Cited by 112
Kashyap, S. R., Belfort, R., Berria, R., Suraamornkul, S., Pratipranawatr, T., Finlayson, J., Barrentine, A., Bajaj, M., Mandarino, L., DeFronzo, R., et al. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00541.2003 · Cited by 103
Self-citationAssociation of ceramides in human plasma with risk factors of atherosclerosis
Ichi, I., Nakahara, K., Miyashita, Y., Hidaka, A., Kutsukake, S., Inoue, K., Maruyama, T., Miwa, Y., Harada‐Shiba, M., Tsushima, M., et al. (2006) · Lipids · doi:10.1007/s11745-006-5041-6 · Cited by 96
González, F., Rote, N. S., Minium, J., & Kirwan, J. P. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06579 · Cited by 76
Self-citationCeramide concentrations in septic patients: A possible marker of multiple organ dysfunction syndrome
Delogu, G., Famularo, G., Amati, F., Signore, L., Antonucci, A., Trinchieri, V., Marzio, L. D., & Cifone, M. G. (1999) · Critical Care Medicine · doi:10.1097/00003246-199911000-00015 · Cited by 60
Serlie, M. J. M., Meijer, A. J., Groener, J. E. M., Durán, M., Endert, E., Fliers, E., Aerts, J. M. F. G., & Sauerwein, H. P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2347 · Cited by 51
González, F., Minium, J., Rote, N. S., & Kirwan, J. P. (2006) · Metabolism · doi:10.1016/j.metabol.2005.08.022 · Cited by 33
Self-citationTumor necrosis factor‐α and ceramides in insulin resistance
Brindley, D. N., Wang, C., Mei, J., Xu, J., & Hanna, A. N. (1999) · Lipids · doi:10.1007/bf02562240 · Cited by 32
Soeda, S., Honda, O., Shimeno, H., et al. (1995) · Thrombosis Research · doi:10.1016/0049-3848(95)00206-5 · Cited by 27
Serlie, M. J. M., Allick, G., Groener, J. E. M., Ackermans, M. T., Heijligenberg, R., Voermans, B. C., Aerts, J. M. F. G., Meijer, A. J., & Sauerwein, H. P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1518 · Cited by 24
Mei, J., Wang, C.-N., O'Brien, L., & Brindley, D. N. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802183 · Cited by 16
Ichi, I., Takashima, Y., Adachi, N., Nakahara, K., Kamikawa, C., Harada‐Shiba, M., & Kojo, S. (2007) · Lipids · doi:10.1007/s11745-007-3067-z · Cited by 15
Cited by
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Self-citationJung, U., & Choi, M.-S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15046184 · Cited by 1,880
The cellular and signaling networks linking the immune system and metabolism in disease
Osborn, O., & Olefsky, J. M. (2012) · Nature Medicine · doi:10.1038/nm.2627 · Cited by 1,551
Insulin Receptor Signaling in Normal and Insulin-Resistant States
Boucher, J., Kleinridders, A., & Kahn, C. R. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009191 · Cited by 1,473
Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis
Guasch-Ferré, M., Hruby, A., Toledo, E., Clish, C. B., Martínez-González, M. A., Salas-Salvadó, J., & Hu, F. B. (2016) · Diabetes Care · doi:10.2337/dc15-2251 · Cited by 905
Metadata
- Authors
- Haus, J. M., Kashyap, S. R., Kasumov, T., Zhang, R., Kelly, K. R., DeFronzo, R. A., & Kirwan, J. P.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-02-01
- Volume
- 58
- Issue
- 2
- Pages
- 337-343
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2100198908
- Cited by
- 663
- References
- 54
- FWCI
- 5.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.